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Objective ： To observe the effect of highdose Astragalus injection and cyclophosphamide （CTX） on infection ， urine protein and immune function of the patients wi th lupus nephritis ． Methods ： Fortythree patients diagnosed as systemic lupus erythematosus （ SLE） complicated by kidney damage and qideficiency syndrome were randomly divided into trial group （ n ＝ ２３） and control group （ n ＝ ２０） ． Patients in both groups were treated for ３ months ． Intravenous drip infusion of ０ ．８ g CTX was administered to all patients once a month ， while intravenous drip infusion of ２０ ml Astragalus injection was only administered to patients in the trial group every day for １２ days in each month ． Results ： The decrease of active clinical symptom score after the treatment in the trial group was greater than that in the control group （ P ＜ ０ ．０５） ． The infection rates of the trial group and the control group were ４ ．３５ ％ and ２５ ％ respectively ． The decrease of ２４hour urine protein and CD８ ， and the increase of red blood cell count and serum albumin in the trial group were greater than those in the control group ， and there were significant differences between the two groups （ P ＜ ０ ．０５ ） ． Whi te blood cell count in the trial group was decreased less than that in the control group after the treatment （ P ＜ ０ ．０５） ． Conclusion ： Highdose Astragalus injection used together with CTX is more effective than CTX alone in decreasing infection rate and urine protein and improving immune function for patients wi th lupus nephri tis ． Keywords ： lupus erythematosus ，systemic ； lupus nephritis ； cyclophosphamide ； Astragalus membranaceus ； intravenous drip Table 1 Comparison of active clinical symptom score between two groups （ x ± s ） G r ou p n Ac ti ve cli nical sy m p t o m sco r e C on t r ol P r et r eat m en t ２ ０ ３ ． ８ ７ ± １ ．５１ Table 2 Comparisons of 24 hour urine protein ， total serum protein ， and serum albumin between two groups （ x ± s ） G r o u p n ２ ４ h ou rs u ri ne p r ot ein （ g ／ ２４ h） S er um al b umin （ g／ L） T o ta l se ru m pr o tein （ g／ L） C on t r ol P r et r eat m en t ２０ ３ ．２６ ± １ ．８６ ３ ０ ．１ ２ ± ６ ．７９ ５８ ．９６ ± １３ ．４３
Po stt r eat m en t
Po stt r eat m en t ２３ １ ．０７ ± ０ ．６０
P ＜ ０ ．０１ ， vs b ef o r e t r eat m en t ； △ P ＜ ０ ．０５ ， vs co n t r ol g r oup ． 表 3 两组治疗前后血常规及血沉的变化 Table 3 Comparisons of blood cell count and ESR between two groups
C on t r ol P r et r eat m en t ２０ ３ ．１７ ± ０ ．４２ ５ ．３ １ ± ０ ．４ ９ １４９ ．８３ ± ４７ ．７ ８ ７７ ．９７ ± ２２ ．８７
Po stt r eat m en t ２０ ３ ．０９ ± ０ ．３７ ３ ．９ １ ± ０ ．８ ２  １４６ ．１２ ± ６１ ．２ ７ ４０ ．７７ ± ２１ ．６１   T ria l P r et r eat m en t ２３ ３ ．１９ ± ０ ．５８ ５ ．２ ７ ± ０ ．５ ５ １５２ ．６１ ± ５８ ．１ ２ ８１ ．４５ ± ２５ ．６５
Po stt r eat m en t ２３ ３ ．６９ ± ０ ．４３  △ ４ ．８ ３ ± １ ．１ ８ △ １５３ ．４５ ± ３７ ．２ １ ３６ ．６３ ± １９ ．７８    P ＜ ０ ．０ ５ ，   P ＜ ０ ．０１ ， vs b ef o r e t r eat m en t ； △ P ＜ ０ ．０５ ， vs co n t r ol g r oup ． 表 4 两组治疗前后 T 细胞亚群的变化 Table 4 Comparison of Tcell subsets between two groups
C on t r ol P r etr ea t m e n t ２０ ７３ ．７９ ± １ ８ ．３ ８ ３６ ．４２ ± １ １ ．３ ５ ３９ ．１７ ± １４ ．３１ P osttr ea t m en t ２０ ６６ ．２７ ± １ ３ ．５ ９ ３９ ．２５ ± １ ３ ．４ １ ４１ ．２３ ± １６ ．２０ T rial P r etr ea t m e n t ２３ ７２ ．１９ ± ２ ０ ．５ ６ ３３ ．７８ ± １ ０ ．８ １ ４０ ．１５ ± １１ ．８８ P osttr ea t m en t ２３ ６８ ．９５ ± １ ８ ．６ ７ ３７ ．６９ ± １ １ ．２ ３ ３３ ．７３ ± １２ ．１１  △  P ＜ ０ ．０ ５ ， vs be fo r e t rea t m e n t ； 
